Skip to main content
Equibles
PTCT logo

PTCT · Ptc Therapeutics, Inc. · Share Buybacks

Track PTCT — free

Use PTCT with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research PTCT.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$63.49 +0.13 (+0.21%) At close · Nov 13 Play latest call Q3 2026 earnings call transcript
S&P 600 member Russell 2000 member Rebalance outlook locked
Customer concentration — top 4 customers 10% of revenue

4 customers — 10% of revenue (2025)

“During 2025, four of our distributors each accounted for over 10% of our net product sales.”
View the 10-K filed Feb 19, 2026
Market Cap
$5.30B
Shares
83.54M
Volume · Nov 13 502.9K Avg daily vol (3M) 1.07M

Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.

Equity Offering (ATM) Programs

Program Established Capacity Remaining Runs Through
2019-08 $125,000,000 $93,000,000 as of 2026-09-30 —
Key facts CIK 1070081 CUSIP 69366J200 13F (30d) 284 filings 256 filers Visit website Investor relations